Wed, October 14, 2020

Vikram Purohit Upgraded (TBPH) to Buy on, Oct 14th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. rohit-upgraded-tbph-to-buy-on-oct-14th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Vikram Purohit of Morgan Stanley, Upgraded "Theravance Biopharma, Inc." (TBPH) to Buy on, Oct 14th, 2020.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $30 on, Monday, August 10th, 2020
  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $29 on, Tuesday, July 7th, 2020